70 related articles for article (PubMed ID: 20955264)
1. Preliminary study with bicalutamide in heterosexual and homosexual patients with prostate cancer: a possible implication of androgens in male homosexual arousal.
Motofei IG; Rowland DL; Popa F; Kreienkamp D; Paunica S
BJU Int; 2011 Jul; 108(1):110-5. PubMed ID: 20955264
[TBL] [Abstract][Full Text] [Related]
2. Atypical onset of bicalutamide-induced liver injury.
Yun GY; Kim SH; Kim SW; Joo JS; Kim JS; Lee ES; Lee BS; Kang SH; Moon HS; Sung JK; Lee HY; Kim KH
World J Gastroenterol; 2016 Apr; 22(15):4062-5. PubMed ID: 27099451
[TBL] [Abstract][Full Text] [Related]
3. Bicalutamide-Induced Hepatotoxicity in a Transgender Male-to-Female Adolescent.
Wilde B; Diamond JB; Laborda TJ; Frank L; O'Gorman MA; Kocolas I
J Adolesc Health; 2024 Jan; 74(1):202-204. PubMed ID: 37791922
[No Abstract] [Full Text] [Related]
4. Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer.
Dickstein DR; Edwards CR; Lehrer EJ; Tarras ES; Gallitto M; Sfakianos J; Galsky MD; Stock R; Safer JD; Rosser BRS; Marshall DC
Nat Rev Urol; 2023 Jun; 20(6):332-355. PubMed ID: 37217695
[TBL] [Abstract][Full Text] [Related]
5. LGBTQI cancer patients' quality of life and distress: A comparison by gender, sexuality, age, cancer type and geographical remoteness.
Ussher JM; Allison K; Perz J; Power R;
Front Oncol; 2022; 12():873642. PubMed ID: 36203463
[TBL] [Abstract][Full Text] [Related]
6. Racial/Ethnic Differences in Health-Related Quality of Life Among Gay and Bisexual Prostate Cancer Survivors.
Bates AJ; Rosser BRS; Polter EJ; Wheldon CW; Talley KMC; Haggart R; Wright M; Mitteldorf D; West W; Ross MW; Konety BR; Kohli N
Front Oncol; 2022; 12():833197. PubMed ID: 35494011
[TBL] [Abstract][Full Text] [Related]
7. What Gay and Bisexual Men Treated for Prostate Cancer Want in a Sexual Rehabilitation Program: Results of the
Rosser BRS; Kohli N; Lesher L; Capistrant BD; DeWitt J; Kilian G; Konety BR; Merengwa E; Mitteldorf D; West W
Urol Pract; 2018 May; 5(3):192-197. PubMed ID: 35261917
[TBL] [Abstract][Full Text] [Related]
8. Recruiting an underserved, difficult to reach population into a cancer trial: Strategies from the
Simon Rosser BR; Wright M; Hoefer CJ; Polter EJ; Kohli N; Wheldon CW; Haggart R; Talley KM; Mitteldorf D; Kilian G; Konety BR; Ross MW; West W
Clin Trials; 2022 Jun; 19(3):239-250. PubMed ID: 35232299
[TBL] [Abstract][Full Text] [Related]
9. Health Disparities of Sexual Minority Patients Following Prostate Cancer Treatment: Results From the
Rosser BRS; Polter EJ; Talley KMC; Wheldon CW; Haggart R; Wright M; West W; Mitteldorf D; Ross MW; Konety BR; Kohli N
Front Oncol; 2022; 12():812117. PubMed ID: 35186749
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity Prevalence and Impact on Quality of Life in Gay and Bisexual Men Following Prostate Cancer Treatment.
Haggart R; Polter E; Ross M; Kohli N; Konety BR; Mitteldorf D; West W; Rosser BRS
Sex Med; 2021 Dec; 9(6):100439. PubMed ID: 34634579
[TBL] [Abstract][Full Text] [Related]
11. Every urologist and oncologist should know about treating sexual and gender minority prostate cancer patients: translating research findings into clinical practice.
Rosser BRS; Rider GN; Kapoor A; Talley KMC; Haggart R; Kohli N; Konety BR; Mitteldorf D; Polter EJ; Ross MW; West W; Wheldon C; Wright M
Transl Androl Urol; 2021 Jul; 10(7):3208-3225. PubMed ID: 34430423
[TBL] [Abstract][Full Text] [Related]
12. Health outcomes of sexual and gender minorities after cancer: a systematic review.
Pratt-Chapman ML; Alpert AB; Castillo DA
Syst Rev; 2021 Jun; 10(1):183. PubMed ID: 34154645
[TBL] [Abstract][Full Text] [Related]
13. Understanding Prostate Cancer in Gay, Bisexual, and Other Men Who Have Sex with Men and Transgender Women: A Review of the Literature.
Rosser BRS; Hunt SL; Capistrant BD; Kohli N; Konety BR; Mitteldorf D; Ross MW; Talley KM; West W
Curr Sex Health Rep; 2019 Dec; 11(4):430-441. PubMed ID: 31929765
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life by human immunodeficiency virus status in a cross-sectional survey of gay and bisexual prostate cancer survivors.
Polter EJ; Wheldon CW; Rosser BRS; Kohli N; Capistrant BD; Kapoor A; Konety B; Mitteldorf D; Ross M; Talley KMC; Terveen L; West W; Wright MM
Psychooncology; 2019 Dec; 28(12):2351-2357. PubMed ID: 31518042
[TBL] [Abstract][Full Text] [Related]
15. Cancer in Sexual and Gender Minority Patients: Are We Addressing Their Needs?
Cathcart-Rake EJ
Curr Oncol Rep; 2018 Sep; 20(11):85. PubMed ID: 30209629
[TBL] [Abstract][Full Text] [Related]
16. The Experiences of Gay and Bisexual Men Post-Prostate Cancer Treatment: A Meta-Synthesis of Qualitative Studies.
Alexis O; Worsley AJ
Am J Mens Health; 2018 Nov; 12(6):2076-2088. PubMed ID: 30112965
[TBL] [Abstract][Full Text] [Related]
17. The effects of radical prostatectomy on gay and bisexual men's sexual functioning and behavior: qualitative results from the restore study.
Rosser BRS; Capistrant B; Torres MB; Konety B; Merengwa E; Mitteldorf D; West W
Sex Relation Ther; 2016; 31(4):432-445. PubMed ID: 30111985
[TBL] [Abstract][Full Text] [Related]
18. Addressing Participant Validity in a Small Internet Health Survey (The Restore Study): Protocol and Recommendations for Survey Response Validation.
Dewitt J; Capistrant B; Kohli N; Rosser BRS; Mitteldorf D; Merengwa E; West W
JMIR Res Protoc; 2018 Apr; 7(4):e96. PubMed ID: 29691203
[TBL] [Abstract][Full Text] [Related]
19. Online Versus Telephone Methods to Recruit and Interview Older Gay and Bisexual Men Treated for Prostate Cancer: Findings from the Restore Study.
Rosser BRS; Capistrant B
JMIR Cancer; 2016 Jul; 2(2):e9. PubMed ID: 28410183
[TBL] [Abstract][Full Text] [Related]
20. Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain.
Motofei IG; Rowland DL; Manea M; Georgescu SR; Păunică I; Sinescu I
Clin Drug Investig; 2017 Jun; 37(6):511-517. PubMed ID: 28161756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
